Wordt geladen...
Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway
Alternative splicing is evolving as an eminent player of oncogenic signaling for tumor development and progression. Mucin 4 (MUC4), a type I membrane-bound mucin, is differentially expressed in pancreatic cancer (PC) and plays a critical role in its progression and metastasis. However, the molecular...
Bewaard in:
| Gepubliceerd in: | Biochim Biophys Acta |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6047753/ https://ncbi.nlm.nih.gov/pubmed/29777904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbadis.2018.05.008 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|